Skip to contentClarengateINTELLIGENCE
Coverage & freshness About Clarengate
Companies/SC476268

The Antibody Company Limited

Research and experimental development on biotechnology · Newmains

ActiveUnited KingdomIncorporated 2014Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-04-30

IXBRL · 165 source facts · 26 selected values

Validation findings
XBRL valid
Reporting period
2024-05-01 to 2025-04-30
Extraction status
complete
Numeric facts
101
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2025-01-01.xsd
Currency
GBP
Source identifier
Prod224_2601_SC476268_20250430
Source archive
Accounts_Monthly_Data-January2026.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-04-30

IXBRL · 165 source facts · 26 selected values

Validation findings
XBRL valid
Reporting period
2023-05-01 to 2024-04-30
Extraction status
complete
Numeric facts
101
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_3500_SC476268_20240430
Source archive
Accounts_Monthly_Data-January2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2023-04-30

IXBRL · 165 source facts · 24 selected values

Not assessed
legacy record
Reporting period
2022-05-01 to 2023-04-30
Extraction status
Legacy / not assessed
Numeric facts
101
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_0030_SC476268_20230430
Source archive
Accounts_Monthly_Data-October2023.zip

Accounts to 2022-04-30

IXBRL · 163 source facts · 26 selected values

Not assessed
legacy record
Reporting period
2021-05-01 to 2022-04-30
Extraction status
Legacy / not assessed
Numeric facts
99
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0110_SC476268_20220430
Source archive
Accounts_Monthly_Data-September2022.zip

Accounts to 2021-04-30

IXBRL · 163 source facts · 26 selected values

Not assessed
legacy record
Reporting period
2020-05-01 to 2021-04-30
Extraction status
Legacy / not assessed
Numeric facts
99
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0094_SC476268_20210430
Source archive
Accounts_Monthly_Data-September2021.zip

Accounts to 2020-04-30

IXBRL · 153 source facts · 26 selected values

Not assessed
legacy record
Reporting period
2019-05-01 to 2020-04-30
Extraction status
Legacy / not assessed
Numeric facts
91
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0086_SC476268_20200430
Source archive
Accounts_Monthly_Data-January2021.zip

Accounts to 2019-04-30

IXBRL · 137 source facts · 22 selected values

Not assessed
legacy record
Reporting period
2018-05-01 to 2019-04-30
Extraction status
Legacy / not assessed
Numeric facts
78
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0074_SC476268_20190430
Source archive
Accounts_Monthly_Data-January2020.zip

Accounts to 2018-04-30

IXBRL · 129 source facts · 18 selected values

Not assessed
legacy record
Reporting period
2017-05-01 to 2018-04-30
Extraction status
Legacy / not assessed
Numeric facts
70
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0062_SC476268_20180430
Source archive
Accounts_Monthly_Data-January2019.zip

Accounts to 2017-04-30

IXBRL · 128 source facts · 18 selected values

Not assessed
legacy record
Reporting period
2016-05-01 to 2017-04-30
Extraction status
Legacy / not assessed
Numeric facts
68
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0050_SC476268_20170430
Source archive
Accounts_Monthly_Data-January2018.zip

Accounts to 2016-04-30

IXBRL · 57 source facts · 20 selected values

Not assessed
legacy record
Reporting period
2015-05-01 to 2016-04-30
Extraction status
Legacy / not assessed
Numeric facts
38
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0035_SC476268_20160430
Source archive
Accounts_Monthly_Data-October2016.zip

Registered details

SC476268
Status
Active
Type
Private Limited Company
Incorporated
2014-04-28
Jurisdiction
—
Registered office
10 CHURCH AVENUE, NEWMAINS, LANARKSHIRE, ML2 9BH

Classification

1 SIC codes
72110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

1 matched grants
Design of highly immunogenic immunogens for development of monoclonal antibodies to selfpeptides: a combined simulation and experimental study
BBSRC · Studentship · 2018-09-30 – 2022-09-29 · with 1 other participant
£0
whole project
University Of StrathclydeleadThe Antibody Company Limited